Attend the largest cancer immunotherapy conference and exhibit at SITC’s 40th Anniversary Annual Meeting, hosted by the leading member-driven organization focused on cancer immunotherapy.
Visit CRI Booth 305 to meet our team, discuss the latest breakthroughs in cancer immunotherapy, and explore new funding opportunities like the CRI IGNITE Award, which supports early-career investigators as they transition to independent research in cancer immunology.
Join our CEO, Alicia Zhou, PhD, who will participate in the panel discussion “The Momentum and Future of Cancer Research Funding” (Concurrent Session 205C). This session is co-chaired by two distinguished members of our Scientific Advisory Council: Ira Mellman, PhD, FAACR, FAIO, and Miriam Merad, MD, PhD, FAIO. The panel will bring together leaders from key research funding agencies to discuss how to sustain momentum and develop innovative funding models that accelerate discovery and drive therapeutic breakthroughs.
